tiprankstipranks
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market
SION
Sionna Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see SION full AI Analyst Report?

Sionna Therapeutics, Inc. (SION) Stock News & Sentiment

27 Followers
Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
Premium
Ratings
Yazdi Reiterates Buy on Sionna, Keeps $58 Price Target Ahead of High-Impact 2026 SION-719 Readout
13d ago
SION
SION Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SION Earnings this Week: How Will it Perform?
2M ago
SION
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
Premium
Ratings
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target
4M ago
SION
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
Premium
Ratings
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
5M ago
SION
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
Premium
Ratings
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
6M ago
SION
Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
Premium
Ratings
Sionna Therapeutics: Promising Developments and Strategic Advancements Boost Price Target
6M ago
SION
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
Premium
Company Announcements
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
7M ago
SION
More SION News >

SION News on the Web

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
TipRanks News
Neutral
Sionna Therapeutics downgraded to Hold from Buy at Freedom Broker
TipRanks News
Bearish
Sionna Therapeutics downgraded at Freedom Broker with unchanged target
TipRanks News
Bearish
LifeSci Capital Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)
TipRanks News
Neutral
Citizens biotechnology analyst holds analyst/industry conference call
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Ironwood Pharma (IRWD), Sionna Therapeutics, Inc. (SION)
TipRanks News
Bullish
RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)
TipRanks News
Bearish
Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)
TipRanks News
Bullish

News Score - Last 7 Days

Very Negative
SION
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.75 articles
News Sentiment
This Week0%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SION’s Media Buzz Sentiment?
2 articles about SION were published this week. In an average week, 4.75 articles are published.
    What is SION’s weekly average amount of articles?
    In an average week, 4.75 articles about SION are published.
      What is SION’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      TLSATiziana Life Sciences
      JUNSJupiter Neurosciences, Inc.
      IMMXImmix Biopharma
      Showing the stocks with the most bullish news sentiment over the past week